-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

705.P1.78 705. Cellular Immunotherapies: Late Phase and Commercially Available Therapies: Poster I

Symposia: Cellular Immunotherapies: Late Phase and Commercially Available Therapies Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, clinical trials, Translational Research, epidemiology, Clinical Research, real-world evidence, registries
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)
The 705 poster session includes prospective, retrospective and translational data regarding commercially-available or late phase development cellular therapies in Hematologic Malignancies

Annalisa Chiappella, MD1, Anna Dodero, MD2*, Beatrice Casadei, MD, PhD3*, Chiara De Philippis4*, Silva Ljevar5*, Eugenio Galli6*, Alice Di Rocco7*, Matteo Giovanni Carrabba8*, Maria Chiara Tisi9*, Maurizio Musso10*, Ilaria Cutini11*, Anna Maria Barbui, MD12*, Mirko Farina, MD13*, Massimo Martino14*, Anna Guidetti2*, Barbara Botto15*, Giovanni Grillo16*, Jacopo Olivieri17*, Martina Pennisi2*, Mauro Krampera18, Marco Ladetto19, Massimo Massaia20, Luca Arcaini21*, Federica Cavallo22*, Rosalba Miceli5*, Maurizio Martelli7*, Patrizia Chiusolo6*, Stefania Bramanti4*, Pier Luigi Zinzani, MD, PhD3 and Paolo Corradini, MD2,23

1Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Milano, Italy
2Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
3IRCCS Azienda Ospedaliero-Universitaria di Bologna  Istituto di Ematologia “Seràgnoli” and Dipartimento di Scienze Mediche e Chirurgiche,  Università di Bologna, Bologna, Italy
4IRCCS Humanitas Research Hospital, Transplantation Unit Department of Oncology and Haematology, Rozzano, Italy
5Unit of Biostatistics for Clinical Research, Department of Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
6Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
7Hematology Section, Department of Traslational and Precision Medicine, Sapienza University of Rome, Roma, Italy
8Unit of Hematology and Bone Marrow Transplantation, I.R.C.C.S. Ospedale San Raffaele, Milan, Italy
9Hematology Unit, San Bortolo Hospital, A.U.L.S.S. 8 "Berica", Vicenza, Italy
10UOC of Oncohematology and TMO, Oncology Department La Maddalena, Palermo, Italy
11SOD Terapie Cellulari e Medicina Trasfusionale, AAD Trapianto di midollo osseo, Ospedale Careggi, Firenze, Italy
12Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
13Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy., Brescia, Italy
14Stem Cell Transplant and Cellular Therapies Unit, Hemato-Oncology and Radiotherapy Department, "Bianchi-Melacrino-Morelli"Hospital, Reggio Calabria, Italy
15Division of Hematology, Città della Salute e della Scienza Hospital and University, Turin, Italy
16Stem Cell Transplantation, Azienda Ospedaliera Ospedale Niguarda Ca' Granda, Milano, Italy
17Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
18Department of Engineering for Innovation Medicine, Section of Medicine and Bone Marrow Transplant Unit, Verona University, Verona, Italy
19Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale, SCDU Ematologia AO SS Antonio e Biagio E Cesare Arrigo, Alessandria, Italy
20Division of Hematology, Santa Croce e Carle Hospital, Cuneo, Italy
21Department of Molecular Medicine, University of Pavia and Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
22Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, A.O.U., Città della Salute e della Scienza di Torino, Torino, Italy
23Chair of Hematology, University of Milano, Milano, Italy

Vishal K Gupta, MD1, Gregory W Roloff, MD2, Lori S. Muffly, MD3, Ibrahim Aldoss, MD4, Noam E. Kopmar, MD5, Chenyu Lin, MD6, Simone E. Dekker, MD, PhD7, Nikeshan Jeyakumar, MD3*, Timothy E O'Connor, MD8, Amy Zhang, PhD9*, Katharine Miller, PhD, MPH9*, Kaitlyn C Dykes, MD10*, Mohamed Ahmed11, Danielle Bradshaw, MD12,13*, Santiago Mercadal, MD14*, Marc Schwartz, MD15*, Sean Tracy, MD, PhD16, Bhagirathbhai Dholaria, MBBS17, Michal Kubiak, MD13, Akash Mukherjee, MD18*, Navneet Majhail, MD, MS, FASTCT19, Minoo Battiwalla, MD20, Luke Mountjoy, DO21, Shabaz Malik, MD22*, John Mathews, MD23*, Paul Shaughnessy, MD24, Aaron C. Logan, MD, PhD25, Abdullah Ladha, MD26*, George Yaghmour, MD27,28, Anjali S. Advani, MD29, Maryann Stefan29*, Caitlin Guzowski, MBA30*, Rasmus T. Hoeg, MD31*, Talal Hilal, MD32, Jozal Moore, MD33, Kristen M. O'Dwyer, MD33, Stephanie B. Tsai, MD, MS8, Joshua Sasine, MD34, Catherine J. Lee, MD35, Vamsi K. Kota, MD13, Divya Koura, MD10, Muthu Veeraputhiran, MD18*, Betsy Blunk36*, Jessica T. Leonard, MD37, Wendy Stock, MD38, Ahmed Galal, MD6, Vinod Pullarkat, MD39, Ryan D Cassaday, MD5, Bijal D. Shah, MD40, Rawan Faramand, MD41 and Caspian H. Oliai, MD42

1University of California Los Angeles, Los Angeles, CA
2University of Chicago, Chicago, IL
3Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
4City of Hope, Duarte, CA
5University of Washington, Seattle, WA
6Duke University School of Medicine, Durham, NC
7Department of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR
8Loyola University, Maywood, IL
9Stanford University School of Medicine, Stanford, CA
10University of California San Diego, La Jolla, CA
11Cedars-Sinai Medical Center, Los Angeles, CA
12Georgia Cancer Center, Augusta University Medical Center, Augusta, GA
13Augusta University, Augusta, GA
14University of Utah, Salt Lake City, UT
15Division of Hematology, University of Colorado, Aurora, CO
16University of Minnesota, Minneapolis, MN
17Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
18University of Arkansas for Medical Sciences, Little Rock, AR
19Sarah Cannon Transplant and Cellular Therapy Network, Nashville, TN
20Sarah Cannon Transplant and Cellular Therapy Program at TriStar Centennial Medical Center, Nashville, TN
21Colorado Blood Cancer Institute and Sarah Cannon Cancer Institute at Presbyterian/St Luke’s Medical Center, Denver, CO
22Sarah Cannon Transplant and Cellular Therapy Program at St. David’s South Austin Medical Center, Austin, TX
23Sarah Cannon and Texas Oncology Transplant and Cellular Therapy Program at Medical City Dallas, Dallas, TX
24Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX
25Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
26University of Southern California, Los Angeles, CA
27Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
28Univeristy of Southern California, Los Angeles, CA
29Cleveland Clinic Foundation, Cleveland, OH
30Northside Hospital Cancer Institute, Atlanta, GA
31Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis, Sacramento, CA
32Mayo Clinic, Phoenix, AZ
33University of Rochester, Rochester, NY
34Cedars-Sinai, Los Angeles, CA
35Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
36Sarah Cannon Research Institute, Nashville, TN
37Oregon Health and Science University, Portland, OR
38University of Chicago Medicine, Chicago, IL
39Hematology/HCT, City of Hope National Medical Center, Duarte, CA
40Moffitt Cancer Center and Research Institute, Tampa, FL
41Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
42Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA

Olalekan O. Oluwole, MBBS1, Patrick M. Reagan, MD2, David B. Miklos, MD, PhD3, Frederick L. Locke, MD4, Andre Goy, MD5, Caron A Jacobson, MD, MMSc6, Javier L. Munoz7, Edouard Forcade, MD, PhD8*, Max S. Topp, MD9*, Dan Zheng, PhD10*, Ana Nunes, PharmD10*, Wangshu Zhang, PhD10*, Rhine R. Shen, PhD10*, Ioana Kloos, MD10*, Marie José Kersten, MD, PhD11 and Michael L. Wang, MD12

1Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
2University of Rochester School of Medicine, Rochester, NY
3Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
4Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
5Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
6Dana-Farber Cancer Institute, Boston, MA
7Banner MD Anderson Cancer Center, Phoenix, AZ
8Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, F-33000, Bordeaux, France
9Medizinische Klinik Und Poliklinik II Universitätsklinikum Wurzburg, Wurzburg, Germany
10Kite, a Gilead Company, Santa Monica, CA
11Amsterdam UMC, Location University of Amsterdam, Cancer Center Amsterdam, on behalf of HOVON/LLPC, Amsterdam, Netherlands
12The University of Texas MD Anderson Cancer Center, Houston, TX

Swetha Kambhampati, MD1, Hai-Lin Wang, MPH2*, Jiali Yan, MS2*, Alex F. Herrera, MD3, Matthew J. Frank, MD, PhD4, Leslie L. Popplewell, MD, FACP, MPH1, Nausheen Ahmed, MD5, Yi Lin, MD, PhD6, Frederick L. Locke, MD7, Paola Ghione, MD, MSEpi8, John G. Gribben, MD, DSc9, Timothy Best2*, Christine Fu, PhD2*, Sara Beygi, MD2*, Markqayne D Ray, PharmD10*, John Bian, PhD2*, Zhen-Huan Hu, MPH2*, Fang Sun, MD, PhD2*, Marcelo Pasquini, MD, MS11 and Caron A Jacobson, MD, MMSc12

1Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
2Kite, a Gilead Company, Santa Monica, CA
3City of Hope, Duarte, CA
4Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
6Mayo Clinic Cancer Center, Rochester, MN
7Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
8Memorial Sloan Kettering Cancer Center, New York, NY
9Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
10Kite, A Gilead Company, Santa Monica, CA
11Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
12Dana-Farber Cancer Institute, Boston, MA

Chiranjeevi Sainatham, MBBS1*, Olga Goloubeva2*, Philip Margiotta, MD3, Hanan Alharthy, MBBS4, Imari Patel3*, Ali Bukhari, MD, MS2, Jennie Law, MD5, Seung Tae Lee, MD6, Mehmet H. Kocoglu, MD7, Jean A. Yared, MD8, Nancy M. Hardy, MD9, Maggie Nelson, PharmD10*, Joseph P McGuirk, DO10, Aaron P. Rapoport, MD2, Saurabh Dahiya11,12* and Forat Lutfi, MD10*

1Internal Medicine, Sinai hospital of Baltimore, BALTIMORE, OH
2University of Maryland, Baltimore, MD
3Hematology- oncology, University of Maryland medical center, Baltimore
4University of Maryland, Baltimore
5University of Maryland Greenbaum Cancer Center, Baltimore, MD
6Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD
7University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
8University of Maryland Marlene and Stewart Comprehensive Cancer Center, Baltimore, MD
9University of Maryland Medical Center, Baltimore, MD
10University of Kansas Medical Center, Westwood, KS
11Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
12University of Maryland Greenbaum Comprehensive Cancer Center, Baltimore, MD

Harper Hubbeling, MD1, Doris Leithner, MD2*, Emily A. Silverman, BS1, Jessica R. Flynn, MS3*, Sean M. Devlin, PhD4*, Gunjan L. Shah5, Beatrice Fregonese, MPH1*, Akshay Bedmutha, MD2*, Beatriz Wills, MD6, Ana Alarcon Tomas, MD7*, Allison Parascondola, MPH8*, Amethyst Saldia, BS8*, Ivan Landego, MD8*, Parastoo B. Dahi, MD7*, Sergio A. Giralt, MD, FACP9, Richard J. Lin, MD, PhD7, Michael Scordo7, Gilles Salles, MD, PhD6, Joachim Yahalom, MD1, Maria Lia Palomba, MD10, Heiko Schoder, MD11*, Miguel-Angel Perales, MD7, Roni Shouval, MD, PhD7 and Brandon S. Imber, MD, MA1

1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
2Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York
4Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
5Adult Bone Marrow Transplant Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
6Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
9Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York
10Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
11Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York

Karlo Perica, MD, PhD1,2, Sarah Nataraj, PhD1*, Maria Lemdal Sjojstrand, PhD3*, Katherine Nagel, NP4*, Emma Pavkovic4*, Erica Payson5*, Ana Cuenca5*, Anjali Patel5*, David Chung, MD, PhD6,7, Sham Mailankody, MBBS8, Gunjan L. Shah7, Saad Z Usmani, MD6,7, Sergio A. Giralt, MD, FACP6,7 and Michel Sadelain, MD PhD9

1Center for Cell Engineering, Memorial Sloan Kettering, New York, NY
2Cellular Therapy Service, Memorial Sloan Kettering, New York, NY
3Sanavia Oncology Inc., New York, NY
4Memorial Sloan Kettering Cancer Center, New York, NY
5Memorial Sloan Kettering, New York, NY
6Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
9Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY

Sushma Bharadwaj, MD, MS1, Eric Lau, DO2, Ayesha Hashmi, MBBS3*, Mark P. Hamilton, MD4, Alexandria Jensen, PhD5*, Anmol Goyal, MD1*, Mallika Marar, MD, MBA3*, Caroline Lee, MD4*, Snegha Ananth, MBBS1, Bita Sahaf, PhD, MSc6*, Jayasindhu Mallampet1*, Zachary Ehlinger7*, Shriya Syal, MS6*, Sunita Patil6*, Henry Guo, MD, PhD8*, Melody Smith, MD, MS9, Wen-Kai Weng, MD, PhD1, Matthew J. Frank, MD, PhD1, Michael S. Binkley, MD, MS10*, David B. Miklos, MD, PhD1 and Saurabh Dahiya1*

1Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
2Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Mountain View, CA
3Department of Radiation Oncology, Stanford University, Stanford, CA
4Division of Hematology and Oncology, Stanford University, Palo Alto, CA
5Quantitative Sciences Unit, Stanford University, Palo Alto, CA
6Cancer Correlative Science Unit, Stanford University, Palo Alto, CA
7Center for Cancer Cell Therapy, Stanford University, Stanford, CA
8Department of Radiology, Stanford University, Palo Alto, CA
9Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA
10Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA

Aya Albittar, MD1*, Jenna M Voutsinas, MPH2*, Andrew J Portuguese, MD1,3, Jennifer J. Huang, MD, PhD1,3, Emily C Liang, MD1,3, Qian Wu1*, Xinyi Fan1*, Alexandre V Hirayama, MD1,4*, Erik L Kimble, MD1,3, Lorenzo Iovino, MD, PhD1,5, Christina Poh, MD1, Ajay K Gopal, MD1, Mazyar Shadman, MD, MPH1*, Brian G Till1, Filippo Milano, MD6, Aude G Chapuis, MD1,7, Ryan D Cassaday, MD1,3, David G Maloney, MD, PhD1,4 and Jordan Gauthier, MD, MSc1,4

1Fred Hutchinson Cancer Center, Seattle, WA
2Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
3University of Washington, Seattle, WA
4Division of Medical Oncology, University of Washington, Seattle, WA
5University of Washington School of Medicine, Seattle, WA
6Fred Hutchinson Cancer Research Center, Seattle, WA
7Division of Hematology and Oncology, University of Washington, Seattle, WA

Omran Saifi, MD1*, William Breen, MD2*, Scott Lester, MD2*, William Rule, MD3*, Bradley Stish, MD4*, Allison C. Rosenthal, DO5, Javier Munoz, MD3*, Yi Lin, MD, PhD6, Patrick B Johnston, MD, PhD4*, Stephen M Ansell, MD, PhD7, Jonas Paludo, MD4, Arushi Khurana, MBBS4, Jose. C. Villasboas, MD4*, Yucai Wang, MD, PhD7, Madiha Iqbal, MD8, Muhamad Alhaj Moustafa, MD9, Hemant S. Murthy, MD10, Ernesto Ayala, MD10, Mohamed A. Kharfan-Dabaja, MD, MBA10, Jennifer Peterson, MD11* and Bradford Hoppe, MD, MPH12*

1Mayo Clinic, Jacksonville, FL
2Department of Radiation Oncology, Mayo Clinic, Rochester, MN
3Mayo Clinic, Phoenix
4Mayo Clinic, Rochester, MN
5Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
6Mayo Clinic Cancer Center, Rochester, MN
7Division of Hematology, Mayo Clinic, Rochester, MN
8Mayo Clinic Florida, Jacksonville, FL
9Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
10Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
11Mayo Clinic, Jacksonville
12Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL

Eugenio Galli1*, Anna Modoni2*, Luca Battistini3*, Monica Rossi, MD4*, Gisella Guerrera3*, Ilaria Pansini5*, Stefan Hohaus4,5*, Andrea Bacigalupo, MD4, Simona Sica4,5*, Patrizia Chiusolo4,5* and Ferderica Sorà4,5*

1Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
2Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
3Unità di Neuroimmunologia, IRCCS Fondazione Santa Lucia, Roma, Italy
4Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
5Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy

Christina Poh, MD1,2, Victor A Chow, MD1,2*, Ryan C Lynch, MD1,2, Chaitra S Ujjani, MD1,2, Mazyar Shadman, MD, MPH1,2, Brian G Till1,2, Vikram Raghunathan, MD1,2*, Edus H Warren, MD, PhD1,2, Jordan Gauthier, MD, MSc1,2, Stephen D Smith, MD1,2, Taran Gujral, PhD1*, Chihiro Morishima, MD1,3*, Qian Wu1*, Jenna M Voutsinas, MPH1*, Amy Sperling2*, Joshua Dizon2*, David G Maloney, MD, PhD1,2 and Ajay K Gopal, MD1,2

1Fred Hutchinson Cancer Center, Seattle, WA
2Division of Hematology and Oncology, University of Washington, Seattle, WA
3Division of Laboratory Medicine, University of Washington, Seattle, WA

Khushali Jhaveri, MD1*, Ram Thapa, PhD1*, Jerald Noble, PhD1*, Dalia Ercan, MS1*, Pranit Singh1*, Johannes Fahrmann, PhD2*, Neeraj Y. Saini, MD3, Ranran Wu, PhD4*, Jennifer Dennison, PhD4*, Samir Hanash, MD PhD2*, Robert R. Jenq, MD5, Karnav Modi, MBBS1*, Nicholas Figura, MD6*, Julio C Chavez, MD7, Bijal D. Shah, MD8, Taiga Nishihori, MD8, Aleksandr Lazaryan, MD, MPH, PhD8, Farhad Khimani, MBBS8*, Christina A Bachmeier, PharmD8*, Kenneth Gage, MD, PhD1*, Asmita Mishra, MD, MBA8, Fabiana Perna, MD, PhD8, Marco Davila, MD, PhD9, Kai Rejeski, MD10, Marion Subklewe, MD11, Frederick L. Locke, MD8, Ciara Louise L. Freeman, MD, PhD, MSc12, Nathan Parker, MPH, PhD1* and Michael D. Jain, MD, PhD8

1Moffitt Cancer Center, Tampa, FL
2Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX
5Departments of Genomic Medicine and Stem Cell Transplantation Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
6Radiation Oncology, Moffitt Cancer Center, Tampa, FL
7Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
8Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
9Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
10LMU University Hospital, Munich, Germany
11Department of Medicine III, LMU University Hospital, LMU Munich, Muenchen, Bavaria, Germany
12Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Andrew J Portuguese, MD1, Aya Albittar, MD1*, Emily C Liang, MD1, Jennifer J. Huang, MD, PhD1, Alexandre V Hirayama, MD1*, Erik L Kimble, MD1, Lorenzo Iovino, MD, PhD1, Christina Poh, MD1, Ajay K Gopal, MD1,2, Mazyar Shadman, MD, MPH3, Brian G Till1, Hans-Peter Kiem1, Filippo Milano, MD4, Aude G Chapuis, MD1, Folashade Otegbeye, MBChB, MPH1, Ryan D Cassaday, MD1, David G Maloney, MD, PhD1 and Jordan Gauthier, MD, MSc3

1Fred Hutchinson Cancer Center, Seattle, WA
2Division of Hematology and Oncology, University of Washington, Seattle, WA
3Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
4Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA

Tariq Kewan, MBBChir1, Sayeef Mirza, MD, MPH2,3, Alexander B Pine, MD, PhD4, Yusuf Rasheed5*, Ramzi Hamouche, MD6, Etienne Leveille, MD-PhD7*, George Goshua, MD, MSc8, Sean X Gu, MD, PhD9*, Yuxin Liu, MD10, Jennifer Vanoudenhove, PhD5, Noffar Bar, MD11, Natalia Neparidze, MD8, Francine M. Foss, MD12, Lohith Gowda, MD13*, Iris Isufi12, Stephanie Halene, MD14, Alfred I Lee, MD, PhD8 and Stuart Seropian, MD15

1Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT
2Yale School of Medicine, NORTH HAVEN, CT
3Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
4Department of Hematology, Yale University School of Medicine/Connecticut VA, West Haven, CT
5Yale University, New Haven, CT
6Department of Hematology, Yale Cancer Center, New Haven, CT
7Center of Molecular and Cellular Oncology, Yale University, New Haven, CT
8Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
9Department of Laboratory Medicine, Yale University School of Medicine, North Haven, CT
10Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, New Haven, CT
11Department of Internal Medicine, Section of Hematology, Yale University School of Medicine and Yale Cancer Center, Cheshire, CT
12Yale University School of Medicine, New Haven, CT
13Yale Cancer Center and Yale School of Medicine, New Haven, CT
14Section of Hematology, Yale Univ. School of Medicine, New Haven, CT
15Yale Univ. School of Med., New Haven, CT

Kevin O. McNerney, MD, MSc1,2*, Vanessa A. Fabrizio, MD3, Aimee C. Talleur, MD4, Stephanie Si Lim, MD5*, Alexandra Dreyzin, MD6,7*, Christina Baggott, PhD8*, Anant Vatsayan, MBBS9, Jenna Rossoff, MD10, Snehit Prabhu, PhD11*, Holly L. Pacenta, MD12*, Christine L Phillips, MD13, Julie-An Talano, MD14, Amy Moskop, MD15*, Michael R Verneris, MD16, Douglas Myers, MD17*, Nicole Karras, MD18*, Challice L. Bonifant, MD, PhD19, Muna Qayed, MD20, Michelle L. Hermiston, MD, PhD21, Prakash Satwani, MD, MBBS22, Christa Krupski, DO, MPH23*, Amy Keating, MD24*, Susanne H.C. Baumeister, MD25, Vasant Chinnabhandar, MD, MBBS26*, Emily Egeler27*, Kevin J Curran, MD28, Crystal L. Mackall, MD29, Theodore W. Laetsch, MD30*, Liora Michal Schultz, MD31 and Swati Naik, MBBS32

1Hematology, Oncology, Neuro-oncology, and Stem Cell Transplant, Lurie Children's Hospital, Chicago, IL
2Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL
3University of Colorado Anschutz, Denver, CO
4Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
5Division of Oncology, John A. Burns School of Medicine, Honolulu, HI
6Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC
7Pediatric Oncology Branch, National Institute of Health, Bethesda, MD
8Stanford university, san francisco
9Children's National Medical Center, Washington, DC
10Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL
11Center for Cancer Cell Therapy, Stanford University, Stanford, CA
12Cook Children's Hospital, Fort Worth, TX
13Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
14Medical College of WI, Milwaukee, WI
15CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
16Children's Hospital Colorado, University of Colorado At Denver, Aurora, CO
17Childrens Mercy Hospital, Kansas City, MO
18City of Hope, Duarte, CA
19Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD
20Emory University, Atlanta, GA
2120University of California San Francisco Benioff Children’s Hospital, San Francisco, CA
22Division of Pediatric Hematology, Oncology and Stem Cell Transplant, Columbia University Medical Center, New York, NY
23Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH
24The Childrens Hospital University of Colorado Denver, Aurora, CO
25Division of Pediatric Oncology, Dana Farber Cancer Inst./Children's Hospital Boston, Boston, MA
26Department of Pediatrics, University of Minnesota Medical School, Minneapolis, MN
27Stanford University School of Medicine, Palo Alto, CA
28Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
29Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA
30Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
31Stanford University School of Medicine, Department of Pediatrics, Division of Hematology and Oncology, Palo Alto, CA
32Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TX

Nicolas Lecornec, MD1*, Marie-Emilie Dourthe, MD, PhD1,2*, Florence Rabian, MD3*, Karima Yakouben, MD1*, Florian Chevillon3*, Delphine Chaillou1*, Sophie Caillat-Zucman, MD4*, Alexis Cuffel4*, Emmanuelle Lesprit, MD5*, Anne Arnould5*, Jérome Naudin6*, Julie Roupret-Serzec1*, Nathalie Parquet, MD7*, Anne Brignier, MD7*, Valerie Guerin-El Khourouj8*, Elodie Lainey, PhD, PharmD9*, Aurélie Caye-Eude10*, Chloe Arfeuille10*, Emmanuelle Clappier, Pharm.D., Ph.D.11,12*, Stéphanie Mathis11*, Marie-Laure Chaix13*, Elie Azoulay, MD14*, Jean-Hugues Dalle1*, Isabelle Madelaine, PharmD15*, Jerome Larghero, PharmD, PhD16*, Nicolas Boissel, MD, PhD17,18* and André Baruchel, MD, PhD1,18

1Department of Pediatric Hematology and Immunology, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
2Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
3Hematology Adolescents and Young Adult Unit, Saint-Louis Hospital, APHP, Paris, France, Paris, France
4Assistance Publique Hôpitaux De Paris, Saint Louis Hospital, Immunology D, Paris, France
5Robert Debré Hospital, EFS, Paris, France
6HôPital Robert Debré, APHP, Paris, FRA
7Apheresis, Saint-Louis Hospital, APHP, Paris, France
8Laboratory of Immunology, Hôpital Universitaire Robert Debré́, AP-HP and Université Paris Cité, Paris, France
9Robert Debre Hospital, Paris, FRA
10Department of Genetics, University Hospital Robert Debré, Assistance Publique Des Hôpitaux, Paris, France
11Laboratoire d'Hématologie, Université Paris Cité, Assistance Publique des Hôpitaux de Paris Nord, Hôpital Saint-Louis, Paris, France
12INSERM U944/CNRS UMR7212, Institut de Recherche Saint- Louis, Université Paris Cité, Paris, France
13Laboratory of Virology, Saint Louis Hospital, APHP, Paris, France
14Saint-Louis Hospital, Paris, AL, France
15Pharmacy department, Saint-Louis Hospital, APHP, Paris, France
16Cell Therapy Unit, Saint-Louis Hospital, APHP, Paris, France
17Hematology Adolescents and Young Adult Unit, Saint-Louis Hospital, APHP, Paris, France, Paris Cedex 10, Paris, France
18Institut Universitaire d'Hématologie, EA-3518, University Hospital Saint-Louis, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France

Maike Breidenbach, MD1,2*, Peter Bader, MD, PhD3, Andishe Attarbaschi, Prof., MD4*, Claudia Rossig, MD5, Roland Meisel, MD6*, Markus Metzler, MD1,7*, Marion Subklewe, MD1,8, Fabian Mueller, MD1,9*, Paul-Gerhardt Schlegel, MD1,10, Irene Teichert von Lüttichau, MD1,11*, Jean-Pierre Bourquin, MD, PhD12, Gabriele Escherich, MD13*, Gunnar Cario, MD14*, Peter Lang, MD, PhD15*, Ramona Krauss, PhD1,2*, Arend von Stackelberg, MD16*, Semjon Willier, MD1,2*, Christina Peters, MD17* and Tobias Feuchtinger, MD1,2

1Bavarian Cancer Research Center (BZKF), R/R ALL Study Group, Bavaria, Germany
2Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, Munich, Germany
3Department of Pediatrics, Division for Stem Cell Transplantation, Immunology and Intensive Care, Goethe University Frankfurt, University Hospital, Frankfurt, Germany
4Department of Pediatric Hematology and Oncology, St. Anna Children’s Hospital, Vienna, Austria
5Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany
6Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany
7Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany
8Department of Medicine III, LMU University Hospital, LMU Munich, Muenchen, Bavaria, Germany
9Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Bavaria, Germany
10Pediatric Hematology and Oncology and Stem Cell Transplantation, University Children's Hospital Wuerzburg, Wuerzburg, Germany
11Department of Pediatrics and Children's Cancer Research Center, TUM School of Medicine, Children’s Hospital Munich Schwabing, Technical University of Munich, Munich, Germany
12Department of Oncology and Children’s Research Center, University Children's Hospital Zurich, Zurich, Switzerland
13Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
14Department of Pediatrics I, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
15Dpt. I - General Pediatrics, Hematology and Oncology, University Children's Hospital Tübingen, Tübingen, Germany
16Department of Pediatric Oncology and Hematology, Charité Universitaetsmedizin Berlin, Berlin, Germany
17Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Vienna, Austria

William Wesson, MPH1, Nausheen Ahmed, MD2, James A Davis, PharmD3*, Mary McGann, PharmD3*, Aliya Rashid, DO, MPH4, Carine Tabak1*, Emerson Logan1*, Jose Marchena-Burgos, MBI5*, Maggie Nelson, PharmD6*, Leyla Shune, MD7,8, Marc Hoffmann, MD9, Al-Ola Abdallah, MD7,8 and Hamza Hashmi, MD7,10*

1University of Kansas School of Medicine, Kansas City, KS
2University of Kansas Cancer Center, Westwood, KS
3Department of Hematology-Oncology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
4Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, MO
5University of Kansas Medical Center, Kansas City
6University of Kansas Medical Center, Westwood, KS
7US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
8Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
9The University of Kansas Medical Center, Kansas City, KS
10Department of Hematology-Oncology, Medical University of South Carolina, Charleston, SC

Ilaria Romano, MD1,2*, Jordan Gauthier, MD, MSc2,3, Ryan C Lynch, MD2,4, Ajay K Gopal, MD2,4, Alexandre V Hirayama, MD2,3*, Kikkeri N Naresh2,5, Alireza Torabi, MD, PhD2, Stephen D Smith, MD2,4, Brian G Till2,4, David G Maloney, MD, PhD2,3, Chaitra S Ujjani, MD2,4, Christina Poh, MD2,4, Filippo Milano, MD4,6, Aude G Chapuis, MD2,4, Mazyar Shadman, MD, MPH2,3 and Lorenzo Iovino, MD, PhD2,7

1Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
2Fred Hutchinson Cancer Center, Seattle, WA
3Division of Medical Oncology, University of Washington, Seattle, WA
4Division of Hematology and Oncology, University of Washington, Seattle, WA
5Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA
6Fred Hutchinson Cancer Research Center, Seattle, WA
7University of Washington School of Medicine, Seattle, WA

Melhem M. Solh, MD1, Asad Bashey, MD, PhD1, Lawrence Morris, MD1, Lizamarie Bachier-Rodriguez, MD1*, H Kent Holland2*, Xu Zhang, PhD3*, Katelin C Jackson1* and Scott R. Solomon, MD1

1Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
2The Blood and Marrow Transplant Program At Northside Hospital, Atlanta, GA
3Center for Clinical and Transitional Sciences,, University of Texas, Houston, TX

Sarah Cayla1*, Benoit Ferment, MD1*, Noemie Bigot2*, Denis Caillot, MD3*, Ingrid Lafon, MD4*, Lionel Karlin5,6*, Anne Lazareth, MD5*, Cyrille Touzeau, MD, PhD7*, Xavier Leleu, MD8, Niels Moya, MD8*, Stephanie Harel, MD1*, Aurore Perrot, MD, PhD9, Pierre Bories, MD, PhD9,10*, Laure Vincent, MD11*, Sylvain Lamure, MD, PhD12*, Mohamad Mohty, MD, PhD13,14, Florent Malard, MD, PhD14*, Salomon Manier, MD, PhD15, Ibrahim Yakoub-Agha, MD, PhD15*, Anne-Marie Stoppa, MD16*, Gabriel Brisou16*, Olivier Decaux, MD, PhD17*, Roch Houot, MD, PhD17*, Steven Le Gouill, MD, PhD18, Jerome Lambert, MD, PhD2*, Thierry Facon, MD19, Herve Avet Loiseau, MD, PhD20, Philippe Moreau, MD, PhD21* and Bertrand Arnulf, MD, PhD22

1Department of Immuno-hematology, Hôpital Saint Louis, APHP, Paris, France
2Biostatistics Department, Hôpital Saint Louis, APHP, Paris, France
3Hematology Department, Dijon University Hospital, Dijon, France
4Service d'Hematologie, Institut de Cancérologie de Bourgogne (ICB), Polyclinique du Parc Drevon (Dijon), Dijon, France
5Department of Hematology, Hospices Civils de Lyon, Lyon Sud University Hospital, Pierre-Bénite, France
6Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France
7Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France
8Department of Oncology-Haematology and Cellular Therapy, Poitiers University Hospital, Poitiers, France
9Department of Hematology, Toulouse University Institute of Cancer, Toulouse, France
10Early Phase Unit, University Cancer Institute Toulouse Oncopole, Toulouse, France
11Department of Clinical Hematology, Montpellier University Hospital Center, Montpellier, France
12Clinical Hematology Department, Montpellier University Hospital, MONTPELLIER, France
13Department of Haematology, Saint Antoine Hospital, Paris, France
14Department of Hematology and Cellular Therapy, Saint-Antoine Hospital, AP-HP, Paris, Paris, France
15Department of Hematology, Lille University Hospital, Lille, France
16Department of Hematology, Institut Paoli-Calmettes, Marseille, France
17Centre Hospitalier Universitaire de Rennes - Hopital Pontchaillou, Rennes, France
18Hematology Department, Institut Curie, Paris, France
19Department of Haematology, Lille University Hospital, Lille, France
20Unité Génomique du Myélome, University Hospital Toulouse, IUCT Oncopole, Toulouse, France
21Department of Hematology, Nantes University Hospital, Nantes, France
22Hôpital Saint-Louis, APHP, Université Paris cite, Paris, France

Amélie Bouvier, MD1*, Amandine Durand, MD2*, Nicolas Gower, MD3*, Cristina Castilla-Llorente, MD4*, Arnaud Campidelli, MD5*, Remy Dulery, MD, PhD6,7*, Jean-Pierre Gangneux, MD8*, Magalie Joris, MD9*, Martin Eloit, MD10*, Amandine Fayard, MD11*, Roberta Di Blasi, MD, PhD12*, Blandine Denis, MD13*, Charles Herbaux, MD, PhD14*, Franck Morschhauser, phd15, Olivier Casasnovas, MD16*, Roch Houot, MD, PhD17*, Cécile Angebault, MD18*, Emmanuel Bachy, MD, PhD19*, Fabien Le Bras, MD20*, Thomas Gastinne, MD21*, Jean-Jacques Tudesq, MD, MSc14* and Giovanna Melica, MD22,23*

1Infectious Diseases and Clinical Immunology Department, Henri Mondor Hospital, Assistance Publique - Hôpitaux de Paris, Créteil, France
2Department of Hematology, University Hospital F. Mitterrand, Dijon, France
3Clinical Hematology, Lille University Hospital, Lille, France
4Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France
5Clinical Hematology, Nancy University Hospital, Vand Uvre Les Nancy, FRA
6INSERM UMRs 938, Sorbonne University, Centre de Recherche Saint-Antoine (CRSA), Paris, France
7Department of Clinical Hematology and Cellular Therapy, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France
8Mycological Biology, Pontchaillou Hospital, Rennes, France
9Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, FRA
10Hematological Intensive Care, Tours University Hospital, Tours, FRA
11Clinical Hematology, Clermont-Ferrand University Hospital, Clermont-Ferrand, France
12Department of Hematology, Assistance Publique Hôpitaux de Paris - Hôpital Saint-Louis, University of Paris, PARIS, France
13Infectious diseases, Saint Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France
14Clinical Hematology Department, Montpellier University Hospital, MONTPELLIER, France
15CHU de Lille, Lille, France
16Clinical Hematology, François Mitterand Hospital, Dijon, FRA
17Clinical Hematology, INSERM U1236, EFS, Hopital Pontchaillou, Rennes University Hospital, Rennes, France
18Parasitological and Mycological Biology, Henri Mondor Hospital, Assistance Publique - Hôpitaux de Paris, Créteil, France
19Clinical Hematology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France
20Clinical Hematology, Henri-Mondor Hospital, Assistance Publique - Hôpitaux de Paris, Paris, FRA
21Clinical Hematology, Nantes University Hospital, Nantes, FRA
22Infectious Diseases and Clinical Immunology Department, Henri Mondor Hospital, Assistance Publique - Hôpitaux de paris, Créteil, France
23Memorial Sloan Kettering Cancer Center, New York, NY, USA, Department of Medicine, Adult Bone Marrow Transplant Service, NYC, NY

Noffar Bar, MD1, Joris Diels2*, Suzy van Sanden2*, João Mendes3*, Teresa Hernando4*, Patricia Cost5*, Jordan M. Schecter6, Nikoletta Lendvai6*, Nitin Patel7*, Tadao Ishida8, Jeremy Er9,10, Simon J. Harrison, MBBS, MRCP, FRCPath, FRACP, PhD11 and Nieves Lopez-Muñoz12*

1Yale New Haven Hospital, New Haven, CT
2Janssen Pharmaceutica NV, Beerse, Belgium
3Janssen-Cilag Farmacêutica, Porto Salvo, Portugal
4Janssen-Cilag, Madrid, Spain
5Janssen Global Services, LLC, Raritan, NJ
6Janssen Research & Development, Raritan, NJ
7Legend Biotech USA Inc., Somerset, NJ
8Japanese Red Cross Medical Center, Tokyo, Japan
9Clinical Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, VIC, Australia
10Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia
11Clinical Haematology and Centre of Excellence for Cellular Immunotherapy, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
12Hospital Universitario 12 de Octubre, Madrid, Spain

Bin Xue, MD1*, Xiu Luo2*, Yifan Liu2*, Lili Zhou2*, Shiguang Ye, MD2*, Shaoguang Li, MD3, Ping Li2* and Aibin Liang, MD, PhD2*

1Department of Hematology, Tongji Hospital of Tongji University, Shanghai, AL, China
2Department of Hematology, Tongji Hospital of Tongji University, Shanghai, China
3Univ. of Massachusetts Medical School, Worcester, MA

Emily C Liang, MD1,2, Aya Albittar, MD1,2*, Andrew J Portuguese, MD1,2, Jennifer J. Huang, MD, PhD1,2, Qian Wu2*, Joseph De Los Reyes, BSA2*, Nikki Pin2*, Aiko Torkelson, BS2*, Delaney Kirchmeier, BS2*, Abigail Chutnik, BS2*, Barbara Pender, MSc2*, Joshua A. Hill, MD1,2*, Rahul Banerjee, MD1,2, Andrew J. Cowan, MD1,2, Damian J Green, MD1,3, Ajay K Gopal, MD2,4, Christina Poh, MD2,4, Mazyar Shadman, MD, MPH2,5, Alexandre V Hirayama, MD2,5*, Brian G Till2,6, Erik L Kimble, MD1,2, Lorenzo Iovino, MD, PhD2,7, Aude G Chapuis, MD2,6, Folashade Otegbeye, MBChB, MPH1,2, Ryan D Cassaday, MD1,2, Filippo Milano, MD3,6, David G Maloney, MD, PhD2,5 and Jordan Gauthier, MD, MSc5,8

1University of Washington, Seattle, WA
2Fred Hutchinson Cancer Center, Seattle, WA
3Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
4Clinical Research Division, Fred Hutch Cancer Center; and Division of Oncology, University of Washington, Seattle, WA
5Division of Medical Oncology, University of Washington, Seattle, WA
6Division of Hematology and Oncology, University of Washington, Seattle, WA
7University of Washington School of Medicine, Seattle, WA
8Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

*signifies non-member of ASH